These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
515 related articles for article (PubMed ID: 18178202)
1. Is positron emission tomography useful in locoregional staging of esophageal cancer? Results of a multidisciplinary initiative comparing CT, positron emission tomography, and EUS. Sandha GS; Severin D; Postema E; McEwan A; Stewart K Gastrointest Endosc; 2008 Mar; 67(3):402-9. PubMed ID: 18178202 [TBL] [Abstract][Full Text] [Related]
2. The role and clinical value of EUS in a multimodality esophageal carcinoma staging program with CT and positron emission tomography. Pfau PR; Perlman SB; Stanko P; Frick TJ; Gopal DV; Said A; Zhang Z; Weigel T Gastrointest Endosc; 2007 Mar; 65(3):377-84. PubMed ID: 17321235 [TBL] [Abstract][Full Text] [Related]
3. The accuracy of endoscopic ultrasonography with fine-needle aspiration, integrated positron emission tomography with computed tomography, and computed tomography in restaging patients with esophageal cancer after neoadjuvant chemoradiotherapy. Cerfolio RJ; Bryant AS; Ohja B; Bartolucci AA; Eloubeidi MA J Thorac Cardiovasc Surg; 2005 Jun; 129(6):1232-41. PubMed ID: 15942562 [TBL] [Abstract][Full Text] [Related]
4. Towards a minimally invasive staging strategy in NSCLC: analysis of PET positive mediastinal lesions by EUS-FNA. Annema JT; Hoekstra OS; Smit EF; Veseliç M; Versteegh MI; Rabe KF Lung Cancer; 2004 Apr; 44(1):53-60. PubMed ID: 15013583 [TBL] [Abstract][Full Text] [Related]
5. The impact of endoscopic ultrasound and computed tomography on the TNM staging of early cancer in Barrett's esophagus. Pech O; May A; Günter E; Gossner L; Ell C Am J Gastroenterol; 2006 Oct; 101(10):2223-9. PubMed ID: 17032186 [TBL] [Abstract][Full Text] [Related]
6. Endoscopic ultrasound-guided fine-needle aspiration when combined with positron emission tomography improves specificity and overall diagnostic accuracy in unexplained mediastinal lymphadenopathy and staging of non-small-cell lung cancer. Kalade AV; Eddie Lau WF; Conron M; Wright GM; Desmond PV; Hicks RJ; Chen R Intern Med J; 2008 Nov; 38(11):837-44. PubMed ID: 19120534 [TBL] [Abstract][Full Text] [Related]
7. Does FDG-PET add information to EUS and CT in the initial management of esophageal cancer? A prospective single center study. McDonough PB; Jones DR; Shen KR; Northup PG; Galysh RL; Hernandez A; White GE; Kahaleh M; Shami VM Am J Gastroenterol; 2008 Mar; 103(3):570-4. PubMed ID: 17941963 [TBL] [Abstract][Full Text] [Related]
8. Importance of fluorodeoxyglucose-positron emission tomography (FDG-PET) and endoscopic ultrasonography parameters in predicting survival following surgery for esophageal cancer. Omloo JM; Sloof GW; Boellaard R; Hoekstra OS; Jager PL; van Dullemen HM; Fockens P; Plukker JT; van Lanschot JJ Endoscopy; 2008 Jun; 40(6):464-71. PubMed ID: 18543134 [TBL] [Abstract][Full Text] [Related]
9. Section III: endoscopic and other staging techniques. Saltzman JR Semin Thorac Cardiovasc Surg; 2003 Apr; 15(2):180-6. PubMed ID: 12838488 [TBL] [Abstract][Full Text] [Related]
10. Routine positron emission tomography does not alter nodal staging in patients undergoing EUS-guided FNA for esophageal cancer. Keswani RN; Early DS; Edmundowicz SA; Meyers BF; Sharma A; Govindan R; Chen J; Kohlmeier C; Azar RR Gastrointest Endosc; 2009 Jun; 69(7):1210-7. PubMed ID: 19012886 [TBL] [Abstract][Full Text] [Related]
11. Value of PET/CT versus enhanced CT for locoregional lymph nodes in non-small cell lung cancer. Yang W; Fu Z; Yu J; Yuan S; Zhang B; Li D; Xing L; Zhao D; Mu D; Sun X; Fang Y; Huang Y; Li W Lung Cancer; 2008 Jul; 61(1):35-43. PubMed ID: 18177978 [TBL] [Abstract][Full Text] [Related]
14. Impact of endoscopic ultrasound combined with fine-needle aspiration biopsy in the management of esophageal cancer. Chang KJ; Soetikno RM; Bastas D; Tu C; Nguyen PT Endoscopy; 2003 Nov; 35(11):962-6. PubMed ID: 14606021 [TBL] [Abstract][Full Text] [Related]
15. The additional value of integrated PET/CT over PET in initial lymph node staging of esophageal cancer. Kato H; Kimura H; Nakajima M; Sakai M; Sano A; Tanaka N; Inose T; Faried A; Saito K; Ieta K; Sohda M; Fukai Y; Miyazaki T; Masuda N; Fukuchi M; Ojima H; Tsukada K; Oriuchi N; Endo K; Kuwano H Oncol Rep; 2008 Oct; 20(4):857-62. PubMed ID: 18813827 [TBL] [Abstract][Full Text] [Related]
16. The role of integrated computed tomography positron-emission tomography in esophageal cancer: staging and assessment of therapeutic response. Erasmus JJ; Munden RF Semin Radiat Oncol; 2007 Jan; 17(1):29-37. PubMed ID: 17185195 [TBL] [Abstract][Full Text] [Related]
17. Ability of positron emission tomography to detect residual neck node disease in patients with head and neck squamous cell carcinoma after definitive chemoradiotherapy. Tan A; Adelstein DJ; Rybicki LA; Saxton JP; Esclamado RM; Wood BG; Lorenz RR; Strome M; Carroll MA Arch Otolaryngol Head Neck Surg; 2007 May; 133(5):435-40. PubMed ID: 17515501 [TBL] [Abstract][Full Text] [Related]
18. Comparative study between endoscopic ultrasonography and positron emission tomography-computed tomography in staging patients with esophageal squamous cell carcinoma. Yen TJ; Chung CS; Wu YW; Yen RF; Cheng MF; Lee JM; Hsu CH; Chang YL; Wang HP Dis Esophagus; 2012 Jan; 25(1):40-7. PubMed ID: 21595776 [TBL] [Abstract][Full Text] [Related]
19. Staging in oesophageal cancer. Plukker JT; van Westreenen HL Best Pract Res Clin Gastroenterol; 2006; 20(5):877-91. PubMed ID: 16997167 [TBL] [Abstract][Full Text] [Related]
20. Preliminary experience comparing routine cytology results with the composite results of digital image analysis and fluorescence in situ hybridization in patients undergoing EUS-guided FNA. Levy MJ; Clain JE; Clayton A; Halling KC; Kipp BR; Rajan E; Roberts LR; Root RM; Sebo TJ; Topazian MD; Wang KK; Wiersema MJ; Gores GJ Gastrointest Endosc; 2007 Sep; 66(3):483-90. PubMed ID: 17725938 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]